Although there have been several studies on EF-Tu expression in different cancer cell lines [20–22], no investigation on EF-Tu expression in gastric adenocarcinoma specimens and correlation analysis between EF-Tu and adenocarcinoma patients’ clinicopathological parameters and prognosis has been carried out to date. This evidence concerns the gene TUFM and gastric adenocarcinoma.